Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MYCN‐non‐amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4S

23 Jul 2008

Abstract excerpt

Stage 4 neuroblastoma (NB) are heterogeneous regarding their clinical presentations and behavior. Indeed infants (stage 4S and non-stage 4S of age <365days at diagnosis) show regression contrasting with progression in children (>365days). Our study aimed at: (i) identifying age-based genomic and gene expression profiles of stage 4 NB supporting this clinical stratification; and (ii) finding a stage 4S NB...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Lung Cancer Research Studies
Share to Neuroblastoma Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19383347
DOI: 10.1016/j.molonc.2008.07.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MYCN‐non‐amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4SPMID 19383347Read ↗

Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastomaSemantic proximity Read ↗

Recent insights into the biology of neuroblastomaSemantic proximity Read ↗

Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastomaSemantic proximity Read ↗

Pediatric cancer genomics, a play rather than a portrait.Semantic proximity Read ↗

Neuroblastoma: biology and staging.Semantic proximity Read ↗

Neuroblastoma: biological insights into a clinical enigma.Semantic proximity Read ↗

Prognostic Significance of Gene Expression Profiles of Metastatic Neuroblastomas Lacking MYCN Gene AmplificationSemantic proximity Read ↗

Molecular mechanisms and therapeutic targets in neuroblastomaSemantic proximity Read ↗

Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) ReportSemantic proximity Read ↗

Bioinformatic analysis of the inner heterogeneity within MYCN non-amplified pediatric neuroblastoma sub-groupSemantic proximity Read ↗

Neuroblastoma in Infants: Long Term Survival from INES Protocols - A SIOPEN StudySemantic proximity Read ↗

Recent biologic and genetic advances in neuroblastoma: Implications for diagnostic, risk stratification, and treatment strategies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.